FDA clearance

Pfizer's Xalkori Gets FDA Approval for ALK-Positive Inflammatory Myofibroblastic Tumors

Angle Gets FDA Clearance for Breast Cancer Cell Isolation System

Lyell Immunopharma's IND for T-Cell Receptor Therapy Gets FDA Clearance

23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test

FDA Clears Jubilant Therapeutics' IND Allowing for LSD1/HDAC6 Inhibitor Clinical Trial

Regor Therapeutics to Begin US CDK2/4/6 Inhibitor Study for HR-Positive, HER2-Negative Breast Cancer

Lyell Immunopharma Receives IND Clearance for Phase I Trial of CAR T-Cell Therapy for ROR1-Expressing TNBC, NSCLC

FDA Approves Thermo Fisher Scientific Oncomine Dx Assay as CDx for Janssen Lung Cancer Drug

Ikena Oncology to Launch Trial of TEAD Inhibitor in Biomarker-Selected Cancers

Precigen to Study Anti-ROR1 CAR T-Cell Therapy for TNBC, Hematologic Cancers

Lion TCR to Begin Phase Ib/II Trial of Autologous Liver Cancer T-Cell Receptor Therapy

Instil Bio to Begin Phase II Trial of TIL Therapy for Advanced Melanoma

InnoCare Pharma to Launch US Trial of ICP-723 for NTRK Fusion-Positive Solid Cancers

FDA Clears IND for Anixa Biosciences, Moffitt Cancer Center's CER-T Therapy for Ovarian Cancer

FDA Clears Thermo Fisher Scientific Oncomine Assay as CDx for Bile Duct Cancer Drug

FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen

FDA Clears IND for Kinnate Biopharma's RAF Inhibitor KIN-2787